We Drive Opportunity

DIA is the catalyst for innovation that improves health globally
Learn More
Risk-Based Thinking in Clinical Trials | August 17 2021

Brought to you in collaboration with MasterControl: Determining which sites need the most attention and how to best address the risks they present requires advanced digital solutions. Register today!

Digital Endpoints Must Meet Patient Needs: One Size Does Not Fit All

Meaningful measures, digital or traditional, help clinicians detect change in what matters to patients

Podcast

Australia: Growing Clinical Trials Even in Pandemic’s Wake

Head of TGA discusses COVID-19 vaccinations, ICMRA, and post-pandemic clinical research and product development in Australia

Listen Now

Global Forum, DIA's Digital Magazine

Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.

Member Spotlight

  • Casey Walker
    people_outline Member Spotlight
    Learn More
    Casey Walker
    “There were a few of her patients who were victims of substance abuse, and seeing how my aunt provided care for them inspired me to discover methods to treat victims such as these with a career in pharmacy.”
    Doctor of Pharmacy Candidate, Howard University
  • Jingsong Wang photo
    people_outline Member Spotlight
    Learn More
    Jingsong Wang
    “We still have a lot of unmet medical and patient needs that can only be addressed when the community (including researchers, physicians, and policymakers) decide to work together. This is happening more and more in recent years, the outcomes of which you see in some of the most advanced medicines and healthcare systems available today.”
    CEO, Harbour BioMed
  • Kim Quaintance-Lunn Photo
    people_outline Member Spotlight
    Learn More
    Kim Quaintance-Lunn
    “The greatest challenge in my view is the lack of harmonization among global health authorities. I will moderate that statement by saying that we should not harmonize for the sake of harmonization. We should harmonize to the best practice.”
    Vice President and Head, Regulatory Policy, North American Regulatory Affairs, Bayer
“There were a few of her patients who were victims of substance abuse, and seeing how my aunt provided care for them inspired me to discover methods to treat victims such as these with a career in pharmacy.”

Casey Walker

Doctor of Pharmacy Candidate, Howard University